Insights from 2023 ESMO Annual Meeting
H

ESMO 2023 Insights: "Omission of Breast Surgery After Neoadjuvant Systemic Therapy for Invasive Cancer - 3-Year Preplanned Primary-Endpoint on a Phase 2 Multicentre Prospective Trial"

By Insights from 2023 ESMO Annual Meeting FEATURING Henry Kuerer
By Insights from 2023 ESMO Annual Meeting FEATURING Henry Kuerer
644 views
October 26, 2023
1 Comment
Login to view comments. Click here to Login

Featured Video

05:59
Lilly Medical Affairs

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Feat. J. O’Shaughnessy

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Related Content

AUTOPLAY
10:53
Kirollos Hanna

Integrating Oral Therapy for Patients With HR+/HER2- Early Stage BC

14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
09:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…

Feat. E. Hamilton
17:39
Yale School of Medicine

2023 Menopause Update

Feat. M. Minkin
28:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials …

Feat. H. Rugo, K. Jhaveri
05:43
Total Health

Neoadjuvant Chemo for HR+ BC: Year in Review

Feat. C. Ma
09:19
Insights from 2023 SABCS

SABCS 2023 Insights: "Biology or Stage? Tailoring Treatment for…

Feat. K. Kalinsky
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
27:01
Scripps Health

CDK4/6 Inhibitor Therapy in Early-Stage HR+/HER2- BC

Feat. S. Sammons
36:18
Insights from ESMO Breast 2024 Annual Meeting

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Feat. H. Rugo
27:04
Fengting Yan

Cancer Screening Molecular Tools

22:34
Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney
10:34
Sara Tolaney

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
16:19
Wassim Mchayleh

Optimizing Adjuvant Treatment in High-Risk HR+/HER2- eBC: Patient Se…

12:07
Sara Tolaney

ESMO 2024 Noteworthy Abstracts in Breast Cancer

Feat. H. Rugo
13:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NATALEE Trial - Baseline Characteristics …

Feat. D. Yardley
10:27
Insights from 2023 SABCS

SABCS 2023 Summary: "What Is the Role for CDK 4/6i in the Adjuv…

Feat. S. Tolaney, H. Rugo
21:31
Insights from ESMO Breast 2024 Annual Meeting

ESMO Breast 2024 Summary: "Community Oncologists Highlights&quo…

Feat. S. Tolaney, H. Rugo